Cochrane · systematic review · CD011478
Type II or type III radical hysterectomy compared to chemoradiotherapy as a primary intervention for stage IB2 cervical cancer
Nama, V, Angelopoulos, G, Twigg, J, et al. · Cochrane Database of Systematic Reviews · 2018 · Cochrane Library
Gynaecological, Neuro-oncology and Orphan CancerAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
4
current version
GRADE rated
2
No studies
2
Included studies
NR
No studies 2 · 50%Ungraded 0 · 0%Very low 2 · 50%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Chemoradiotherapy versus radical surgery for stage IB2 cervical cancers
Population: women (18 years and older) diagnosed with stage IB2 cervical cancer
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Overall survival (5‐year) Chemoradiotherapy vs radical surgery | no estimate extracted | NR | Very low Downgraded: risk of bias |
Progression‐free survival (5‐year) Chemoradiotherapy vs radical surgery | no estimate extracted | NR | No studies |
Recurrence Chemoradiotherapy vs radical surgery | OR 2.26 [1.24, 4.14] | 1 study · 215 participants | Very low Downgraded: risk of bias |
Adverse events: lymphoedema Chemoradiotherapy vs radical surgery | no estimate extracted | NR | No studies |